<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_METU_HS_Ankara_Part_Collection skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:METU HS Ankara/Part Collection</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV id="tzwrapper"><HEADER class="tz-headerHome tz-homeType2 tz-homeTypeRelative"><DIV class="tz-header-content"><DIV class="container"><DIV class="tzHeaderContainer"><NAV class="nav-collapse pull-right tz-menu"><UL id="tz-navbar-collapse" class="nav navbar-nav collapse navbar-collapse tz-nav"><LI><A href="https://2016.igem.org/Team:METU_HS_Ankara">Home</A></LI><LI><A href="#">Team</A></LI><LI class="menu-item"><A href="https://2016.igem.org/Team:METU_HS_Ankara/Team">Team</A></LI><LI class="menu-item"><A href="https://2016.igem.org/Team:METU_HS_Ankara/Collaborations">Collaborations</A></LI></UL><LI><A href="#slider_meetup">Project</A></LI><LI class="menu-item"><A href="https://2016.igem.org/Team:METU_HS_Ankara/Description">Description</A></LI><LI class="menu-item"><A href="https://2016.igem.org/Team:METU_HS_Ankara/Design">Design</A></LI><LI class="menu-item"><A href="https://2016.igem.org/Team:METU_HS_Ankara/Experiments">Experiments</A></LI><LI class="menu-item"><A href="https://2016.igem.org/Team:METU_HS_Ankara/Proof">Proof of Concept</A></LI><LI class="menu-item"><A href="https://2016.igem.org/Team:METU_HS_Ankara/Demonstrate">Demonstrate</A></LI><LI class="menu-item"><A href="https://2016.igem.org/Team:METU_HS_Ankara/Results">Results</A></LI><LI class="menu-item"><A href="https://2016.igem.org/Team:METU_HS_Ankara/Notebook">Notebook</A></LI><LI><A href="#agenda">Parts</A></LI><LI class="menu-item"><A href="https://2016.igem.org/Team:METU_HS_Ankara/Basic_Part">Basic Parts</A></LI><LI class="menu-item"><A href="https://2016.igem.org/Team:METU_HS_Ankara/Composite_Part">Composite Parts</A></LI><LI class="menu-item"><A href="https://2016.igem.org/Team:METU_HS_Ankara/Part_Collection">Part Collection</A></LI><LI><A href="https://2016.igem.org/Team:METU_HS_Ankara/Model">Model</A></LI><LI><A href="https://2016.igem.org/Team:METU_HS_Ankara/Attributions">Attributions</A></LI><LI><A href="https://2016.igem.org/Team:METU_HS_Ankara/Human_Practices">Human Practice</A></LI><LI><A href="https://2016.igem.org/Team:METU_HS_Ankara/Safety">Safety</A></LI><LI><A href="https://2016.igem.org/Team:METU_HS_Ankara/Achievements">Achievements</A></LI><LI><A href="https://2016.igem.org/Team:METU_HS_Ankara/Gallery">Gallery</A></LI></NAV></DIV></DIV></DIV></HEADER><SECTION class="tz-sectionBreadcrumb tzSpace_default vc_row"><DIV class="container"><DIV class="row"><DIV class="col-lg-6 col-md-6 col-sm-12 col-xs-12"><DIV class="tz_breadcrumb_single_cat_title"><H4>Part Collection</H4></DIV></DIV></DIV></DIV></SECTION><SECTION id="our_speakers"><DIV class="container"><DIV class="col-lg-12 col-md-12"><P>Our project consists of two stages; binding and treatment. For binding stage we used a protein called FimH. FimH is the protein that is present at the end of the type 1 pili, the hair like appendages found outside of E.coli. FimH enables the bacteria to bind to mannose sugar found outside of eukaryotic cells. (Krogfelt, Bergmans &amp; Klemm, 1990) Since that was not a specific type of binding, we inserted RPMrel, a tumor specific binding peptide (Kelly &amp; Jones, 2003) into FimH so that our genetically engineered E.coli will bind specifically to the tumor cells (part: K2052014). For treatment stage we used an enzyme called ButCoAT, the enzyme that directly converts Acetyl CoA into our agent, Butyrate. (Parts: K2052015 and K2052018) ButCoAT can be found in Roseburia intestinalis L1-82.(Duncan, S. H., et al., 2002) To combine those two stages we designed parts K2052016 which consists of FimH and ButCoAT together with terminator (B0015), arabinose promoter (K206000) and RBS (B0034).</P><I>The figure shows our plasmid design.</I><P>We made a part collection which enables E.Coli to bind to cancerous cells in the colon flora and secrete  Butyrate when all parts work together as a group. We wanted to ensure that our E.Coli doesn’t secrete Butyrate without binding to cancer cells,  so we made our part collection considering the consistency of basic parts.</P><P>On the other hand, we used the part FimH + RPMrel ( K1850010 ) in order to bind our E.Coli to cancerous cells. But we should use some other basic and composite parts to form a collection and make our part work perfectly and in an order. BBa_B0034 is used as RBS which is needed to make the bacteria read the part perfectly and produce the proteins. BBa_B0015 is used as a terminator to stop the reading and producing process. BBa_K206000 is an arabinose promoter which is really important for our part. When FimH + RPMrel production starts and E.Coli binds to cancer cells  , Arabinose Induced Promoter ( K206000 ) becomes activated with the addition of arabinose into environment. The fact that we shouldn't produce ButCoAT without binding to cancerous cells, arabinose promoter is a really helpfull part for our collection. </P><H3>References</H3><P>
                   1. Krogfelt, K.A., Bergmans H, Klemm P. (1990). “Direct evidence that the FimH protein is the mannose-specific adhesin of Escherichia coli type 1 fimbriae.”
               </P><P>
                   2. Kelly, K. A., Jones, D. A. (2003). “Isolation of a Colon Tumor Specific Binding Peptide Using Phage Display Selection”
               </P><P>
                   3. Duncan, S. H., Hold G. L., Barcenilla A., Stewart C. S., Flint H. J. (2002). “Roseburia intestinalis sp. nov., a novel saccharolytic, butyrate-producing bacterium from human faces”
               </P></DIV></DIV></SECTION></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>